Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Advances In Stem Cell Research: New Interdisciplinary Volume
In a variety of organisms, from zebrafish to fruit flies to humans, stem cells have the potential to differentiate into a variety of tissues--and, in some cases, to give rise to a complete new organism. Stem cell research, therefore, has attracted the attention of a range of biologists--reproductive biologists, cancer biologists, cell and developmental biologists, and others--who have all recognized its importance and therapeutic potential.
generic viagra online
GOP Senators Signal They Will Not Block Sotomayor; Full Senate Vote Expected By Aug. 7
Senate Republicans on Thursday said that they do not plan to block a vote on Supreme Court nominee Sonia Sotomayor, the Washington Post reports. Senate Judiciary Committee ranking member Jeff Sessions (R-Ala.) told Sotomayor that he would not support any effort to filibuster her nomination, meaning that she would need a simple majority of 50 votes to be confirmed. Because Democrats hold 60 votes in the Senate, Sessions" comments effectively end "any possible suspense over her fate," according to the Post (Kane et al., Washington Post, 7/17). Sessions said, "I will not support and I don"t think any member of this side will support a filibuster or any attempt to block a vote on your nomination," adding, "I look forward to you getting that vote before we recess in August." According to CQ Politics, Sessions" statement that Republicans will not filibuster "is bound to rile conservative activists," who have urged GOP senators to delay the vote to allow more time to build opposition.Sen. Lindsey Graham (R-S.C.) also signaled that he would vote for Sotomayor"s confirmation (Perine, CQ Politics, 7/16). He said, "We"ll see what your future holds, but I think it"s going to be pretty bright" (Bendavid, "Washington Wire," Wall Street Journal, 7/16). Sen. James Inhofe (R-Okla.) said that although he will not support Sotomayor"s confirmation, he will not filibuster the vote (Rushing, The Hill, 7/16). Sen. Tom Coburn (R-Okla.) told Sotomayor, "Thank you for giving us such a cordial response, and I am mightily impressed" (Washington Post, 7/17).Voting Timeline UnclearSenate Judiciary Committee Chair Patrick Leahy (D-Vt.) said he would schedule a committee vote on the nomination for July 21. It remains unclear whether committee Republicans will delay the vote until July 28, as they are permitted to do under committee rules. Sessions called the July 21 vote "unrealistic," adding that there "will be a number of questions submitted to the nominee that take some time" (CQ Politics, 7/16). A party-line vote on the nomination does not seem likely, as a number of committee Republicans have praised Sotomayor and signaled that they will vote to confirm her, the AP/Boston Globe reports (Holland, AP/Boston Globe, 7/17). The committee"s vote serves as a recommendation to the full Senate, which likely will hold its final roll-call vote on the nomination by Aug. 7 (Washington Post, 7/17). Senate Majority Leader Harry Reid (D-Nev.) on Thursday said he wants a floor vote on Sotomayor "as quickly as possible" (Brady, Roll Call, 7/16).During the hearing on Thursday, Sotomayor reiterated that she would consider each case individually and declined to state her specific views on abortion rights. In response to Coburn, she said, "Would you want a ... nominee who came in here and said, "I agree with you. This is unconstitutional," before I had a case before me?" She added, "I don"t know that that"s a justice that I can be" (Kiely/Biskupic, USA Today, 7/17). According to the New York Times, "Some observers thought they detected her tipping her hand on abortion rights when she said Supreme Court precedents required abortion restrictions to make exceptions for a woman"s health" (Savage, New York Times, 7/17).
News of the day
Also In Global Health News: Uganda ARVs; Malaria In Yemen; Seasonal Hunger; Zimbabwe Maternal Deaths; Nigeria Polio Campaign
Lack Of Funds Prevents HIV-Positive People In Uganda From Receiving Antiretroviral Treatment

Comparative Effectiveness Research Recommendations.

Statement by APTA President R. Scott Ward, PT, PhD On Tuesday, June 30, the Institute of Medicine (IOM) and the Federal Coordinating Council for Comparative Effectiveness Research released their recommendations on comparative effectiveness research priorities that should be funded by the $1.1 billion made available under the American Recovery and Reinvestment Act (ARRA). I am pleased to report that many of the priorities outlined by IOM and the council include research that will draw conclusions about physical therapy intervention as compared with pharmaceutical and medical management.

Call For Public Debates On Future Uses Of Stem Cells Lead By Bioethicists.

More than 40 scientists, bioethicists, lawyers and science journal editors are calling on their colleagues, policy makers and the public to begin developing guidelines for the research and reproductive use of stem cell-derived eggs and sperm, even though such use may be a decade or more away. "Science has always moved faster than social debate or society"s ability to grapple with these issues," says Debra Mathews, Ph.D., lead author of a paper published in the July issue of Cell Stem Cell and assistant director of science programs at the Johns Hopkins Berman Institute of Bioethics. The paper calls for all parties to begin engaging in open discussion and debates, and describes the need for informed social policy well in advance of the eventual use of eggs and sperm derived from pluripotent stem cells.

UCLA Scientists Find Molecular Differences Between Embryonic Stem Cells And Reprogrammed Skin Cells.

UCLA researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. The data from the study suggest that embryonic stem cells and the reprogrammed cells, known as induced pluripotent stem (iPS) cells, have overlapping but still distinct gene expression signatures. The differing signatures were evident regardless of where the cell lines were generated, the methods by which they were derived or the species from which they were isolated, said Bill Lowry, a researcher with the Broad Stem Cell Research Center and a study author. "We need to keep in mind that iPS cells are not perfectly similar to embryonic stem cells," said Lowry, an assistant professor of molecular, cell and developmental biology. "We"re not sure what this means with regard to the biology of pluripotent stem cells.

IKARIA(R) To In-License BioLineRx's BL-1040.

Ikaria Holdings, Inc. and BioLineRx Ltd. (TASE: BLRX) announced that Ikaria has entered into an agreement to obtain a worldwide exclusive license to BioLineRx"s BL-1040, a potential breakthrough treatment for preventing pathological cardiac remodeling following acute myocardial infarction (AMI). BL-1040, currently in a phase I/II clinical trial, is administered via the coronary artery during standard catheterization and flows into the damaged heart muscle, where it forms a protective "scaffold" that enhances the mechanical strength of the heart muscle during recovery and repair. BL-1040 is the first program to graduate from the BIJ (BioLine Innovations Jerusalem) incubator subsidized by the Israeli Office of the Chief Scientist. Under the terms of the agreement, BioLineRx will receive upfront and milestone payments. BioLineRx will also receive royalties on annual net sales. Ikaria will be responsible for completing clinical development and commercialization efforts.


© Copyright 2009